SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $113,000 | -82.1% | 1,568 | -65.1% | 0.00% | -85.7% |
| Q3 2019 | $631,000 | -27.1% | 4,497 | -4.8% | 0.01% | -26.3% |
| Q2 2019 | $865,000 | +11.8% | 4,722 | -2.9% | 0.02% | +11.8% |
| Q1 2019 | $774,000 | +102.6% | 4,865 | +21.9% | 0.02% | +88.9% |
| Q4 2018 | $382,000 | -37.4% | 3,991 | -7.6% | 0.01% | -35.7% |
| Q3 2018 | $610,000 | -1.1% | 4,319 | +9.6% | 0.01% | -6.7% |
| Q2 2018 | $617,000 | +84.2% | 3,942 | +89.3% | 0.02% | +87.5% |
| Q1 2018 | $335,000 | +174.6% | 2,082 | +7.1% | 0.01% | +166.7% |
| Q3 2017 | $122,000 | +306.7% | 1,944 | +412.9% | 0.00% | +200.0% |
| Q2 2017 | $30,000 | +11.1% | 379 | -1.0% | 0.00% | 0.0% |
| Q1 2017 | $27,000 | – | 383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |